Antibodies and Reagents for SARS-CoV-2 Research


In support of researchers uncovering mechanisms of the SARS-CoV-2 infection, we are continually developing new antibodies, kits, and reagents to help end the COVID-19 pandemic. This page will be updated regularly to provide the latest status for key targets. If you do not see your target of interest, please contact us directly.

For Research Use Only. Not For Use In Diagnostic Procedures.

Sign up to be the first to know about new SARS-CoV-2 product releases

Detection Kits and Assays

Targets Products
Serological Assay SARS-CoV-2 Spike Protein Serological IgG ELISA Kit #20154 New Assays In Development  


Target Products
SARS-CoV-2 Spike Protein New Antibodies In Development    
SARS-CoV-2 Nucleocapsid Protein New Antibodies In Development    
Human ACE2 ACE2 Antibody #4355 ACE2 (OTI1D6) Mouse mAb #15983 Monoclonal Antibodies In Development
Human Immunoglobulin Anti-Human IgG, FC gamma Fragment Specific, HRP-Linked Antibody #32935 Anti-Human IgM, Fc5µ Fragment Specific, HRP-Linked Antibody #51821 Anti-Human IgA, alpha-Chain Specific, HRP-Linked Antibody #80403


  • Custom Conjugation Services: save time and avoid the pitfalls of conjugating your own antibody, with validation, optimization, and testing by CST
  • Carrier Free Formulation: simplify assay development and ensure compatibility with your preferred platform by requesting your antibody without BSA
  • Proteomics Services: send your cellular samples for proteomics analysis to monitor viral protein modifications and host cell signaling response

Host Response to Viral Infection